Human Bone Marrow CD36+ Early Erythroid Progenitor Cells

Description

Human Bone Marrow CD36+ Early Erythroid Progenitor Cells are a type of hematopoietic progenitor cell that is directed to erythroid differentiation. They are mainly derived from bone marrow CD34+ hematopoietic stem/progenitor cells (HSPCs) that are cultured in vitro under the stimulation of specific cytokines (such as EPO and SCF). Morphologically, these cells are usually round or oval, with a high nuclear-to-cytoplasmic ratio and basophilic cytoplasm. Human Bone Marrow CD36+ Early Erythroid Progenitor Cells are involved in early erythropoiesis and exhibit molecular features associated with erythroid lineage commitment. These cells represent a defined stage within bone marrow erythropoiesis and are characterized by CD36 marker expression, displaying distinct early erythroid progenitor features at both phenotypic and transcriptional levels. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.